Inogen Inc (INGN) Stock Price, Quote & News

Company Profile

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators;...

Industry: Medical Devices

Sector: Healthcare

Phone: 805 562 0500

Website: www.inogen.com

Address:

859 Ward Drive, Goleta, United States

mmqwerty00 Aug. 1 at 2:32 AM

$INGN Compare the current assets to the total liabilities and its +90M as of 3/31 - right now this is a 170MC - you think their entire business isn't worth more than 80M. Really? They are guiding 350M+ of sales at EBITDA breakeven with 5-6% growth. No reason why this stock shouldnt be a 10+. Discount the 90M of actual assets on the books. At 10 that values the business at < 180M or about 0.5 sales. Buy it and be patient. May be a wait but no reason why over the next 12-18 months this isn't over 10+ - they have plenty of cash - the business is there and recovering. Its a solid buy

0 · Reply

ZacksResearch Jul. 16 at 2:29 PM

$INGN poised for growth — why the POC market is a game-changer! 🚀 🩺 First-quarter revenues up 5.5% YoY, with domestic sales rising 29.9% and international sales increasing 22.9%. 📈 POCs market projected to grow from $15.05B in 2024 to $22.63B by 2029. 💡 New product launches like Voxi 5 & strategic collaborations to drive future growth. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2585365/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2585365-body-2050&ADID=SYND_STOCKTWITS_TWEET_2_2585365_BODY_2050

0 · Reply

ZacksResearch Jul. 16 at 12:50 PM

$INGN looks ready to breathe new life into your portfolio 👀 Expanding its product lineup and strong potential in portable oxygen concentrators (POC) are fueling bullish sentiment. Full breakdown here 👉 https://www.zacks.com/stock/news/2585365/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2585365-teaser-1977&ADID=SYND_STOCKTWITS_TWEET_2_2585365_TEASER_1977

0 · Reply

MoneyTree82 Jun. 17 at 4:53 PM

$INGN low float very few shares available… would take much for this to pop hard!

0 · Reply

JarvisFlow Jun. 16 at 5:32 PM

B. Riley Securities has updated their rating for Inogen ( $INGN ) to Buy with a price target of 14.

0 · Reply

ZacksResearch May. 28 at 2:50 PM

Is $INGN set for a rebound? 📈 Despite a 21.4% decline so far this year, Inogen's strong Q1 results and attractive P/S ratio of 0.6X vs. the industry's 2.6X show promise. The Zacks Rank #2 stock also projects 7.2% earnings growth for 2025, with continued momentum in the POC space. See why this could be a buying opportunity 👉 https://www.zacks.com/commentary/2478116/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2478116-body&ADID=SYND_STOCKTWITS_TWEET_2_2478116_BODY

0 · Reply

ZacksResearch May. 28 at 12:47 PM

Expanding product portfolio and high prospects for POC raise optimism for $INGN stock. Explore further: https://www.zacks.com/stock/news/2478116/heres-why-you-should-add-inogen-stock-to-your-portfolio-now?cid=sm-stocktwits-2-2478116-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2478116_TEASER

0 · Reply

MoneyTree82 May. 27 at 2:38 PM

$INGN only 26 million share with improving revenues 💪

0 · Reply

ZacksResearch May. 27 at 1:12 PM

Broker upgrades boost $URBN, $INGN and $SWX, with earnings growth and strong Zacks Ranks signaling potential upside despite market volatility. Here's more: https://www.zacks.com/stock/news/2477604/3-stocks-with-upgraded-broker-ratings-to-bet-on-amid-uncertainties?cid=sm-stocktwits-2-2477604-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477604_TEASER

0 · Reply

ZacksResearch May. 27 at 12:12 PM

Trade war jitters or a buying opportunity? Here's why $URBN, $INGN & $SWX might shine! 🚀 ✅ Urban Outfitters: Fiscal 2026 earnings to rise 20% with a 9.1% broker rating upgrade. ✅ Inogen: 2025 earnings projected to grow 24.3%, broker ratings up 25%. ✅ Southwest Gas: 2025 earnings expected to increase 18.4%, with a 14.3% broker rating boost. Discover the full potential here 👉 https://www.zacks.com/commentary/2477604/3-stocks-with-upgraded-broker-ratings-to-bet-on-amid-uncertainties?cid=sm-stocktwits-2-2477604-body&ADID=SYND_STOCKTWITS_TWEET_2_2477604_BODY

0 · Reply

Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025

Jun 23, 2025, 8:30 AM EDT - 6 weeks ago

Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy

May 22, 2025, 1:38 PM EDT - 2 months ago

Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough

May 7, 2025, 8:16 PM EDT - 3 months ago

Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript

May 7, 2025, 4:05 PM EDT - 3 months ago

Inogen Announces First Quarter 2025 Financial Results

Mar 20, 2025, 8:30 AM EDT - 4 months ago

Inogen To Present at 24th Annual Needham Virtual Healthcare Conference

Mar 1, 2025, 8:56 AM EST - 5 months ago

A Volatile Share Price Masks Some Of The Progress At Inogen

Feb 26, 2025, 4:21 PM EST - 5 months ago

What's Going On With MedTech Focused Inogen Stock On Wednesday?

Feb 25, 2025, 8:03 PM EST - 5 months ago

Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 5 months ago

Inogen Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 3, 2025, 4:00 PM EST - 6 months ago

Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West

Jan 26, 2025, 10:17 PM EST - 6 months ago

Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Jan 26, 2025, 12:00 PM EST - 6 months ago

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

Jan 13, 2025, 4:00 PM EST - 7 months ago

Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Dec 30, 2024, 8:30 AM EST - 7 months ago

Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device

Nov 9, 2024, 9:55 PM EST - 9 months ago

Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 4:05 PM EST - 9 months ago

Inogen Announces Third Quarter 2024 Financial Results

Nov 4, 2024, 8:30 AM EST - 9 months ago

Inogen to Present at Upcoming Investor Conferences

Oct 17, 2024, 8:30 AM EDT - 10 months ago

Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024

Oct 8, 2024, 8:30 AM EDT - 10 months ago

Inogen Launches Rove 4 Portable Oxygen Concentrator, Delivering the Highest Oxygen Output in the Lightest Weight 4-Setting POC

Sep 5, 2024, 8:30 AM EDT - 11 months ago

Inogen Appoints Eric Pauls as Vice President of Sales, North America

Aug 6, 2024, 9:11 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript

Aug 6, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Second Quarter 2024 Financial Results

Jul 16, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024

Jul 3, 2024, 4:10 PM EDT - 1 year ago

Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development

Jun 3, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio

May 7, 2024, 10:30 PM EDT - 1 year ago

Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript

May 7, 2024, 4:05 PM EDT - 1 year ago

Inogen Announces First Quarter 2024 Financial Results

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Inogen to Report First Quarter 2024 Financial Results on May 7, 2024

Mar 25, 2024, 8:30 AM EDT - 1 year ago

Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference

Mar 7, 2024, 4:00 PM EST - 1 year ago

Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Feb 27, 2024, 7:09 PM EST - 1 year ago

Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript

Feb 27, 2024, 4:05 PM EST - 1 year ago

Inogen Announces Fourth Quarter and Full-Year 2023 Financial Results

Jan 30, 2024, 4:00 PM EST - 1 year ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Jan 24, 2024, 4:00 PM EST - 1 year ago

Inogen Names Michael Bourque as New Chief Financial Officer

Jan 1, 2024, 8:47 AM EST - 1 year ago

Inogen: Time To Be Greedy When Others Are Fearful

Nov 9, 2023, 2:30 PM EST - 1 year ago

Inogen to Present at Upcoming Investor Conferences in November 2023

Nov 7, 2023, 11:08 PM EST - 1 year ago

Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript

Nov 7, 2023, 4:05 PM EST - 1 year ago

Inogen Announces Third Quarter 2023 Financial Results

Oct 10, 2023, 4:00 PM EDT - 1 year ago

Inogen to Report Third Quarter 2023 Financial Results on November 7, 2023

Sep 18, 2023, 8:30 AM EDT - 2 years ago

Inogen Completes Acquisition of Physio-Assist

Sep 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Announces CFO Transition Plan

Aug 8, 2023, 8:30 AM EDT - 2 years ago

Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program

Aug 7, 2023, 9:46 PM EDT - 2 years ago

Inogen, Inc. (INGN) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:01 PM EDT - 2 years ago

Inogen Announces Second Quarter 2023 Financial Results

Aug 7, 2023, 8:30 AM EDT - 2 years ago

Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators

Jul 18, 2023, 8:54 AM EDT - 2 years ago

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This MonthSilk Road Me

FGEN SILK THRX

Jul 13, 2023, 10:13 PM EDT - 2 years ago

Inogen: Still Struggling, But Very Cheap - Upgrading To Buy

Jul 13, 2023, 8:30 AM EDT - 2 years ago

Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist

May 15, 2023, 5:37 PM EDT - 2 years ago

Inogen to Present at 43rd Annual William Blair Growth Stock Conference

mmqwerty00 Aug. 1 at 2:32 AM

0 · Reply

ZacksResearch Jul. 16 at 2:29 PM

0 · Reply

ZacksResearch Jul. 16 at 12:50 PM

0 · Reply

MoneyTree82 Jun. 17 at 4:53 PM

$INGN low float very few shares available… would take much for this to pop hard!

0 · Reply

JarvisFlow Jun. 16 at 5:32 PM

B. Riley Securities has updated their rating for Inogen ( $INGN ) to Buy with a price target of 14.

0 · Reply

ZacksResearch May. 28 at 2:50 PM

0 · Reply

ZacksResearch May. 28 at 12:47 PM

0 · Reply

MoneyTree82 May. 27 at 2:38 PM

$INGN only 26 million share with improving revenues 💪

0 · Reply

ZacksResearch May. 27 at 1:12 PM

0 · Reply

ZacksResearch May. 27 at 12:12 PM

0 · Reply

RunnerSignals May. 22 at 9:39 PM

Fresh Upgrades and Downgrades After-Hours! $CR $INGN $GRFS $MU $SWK and more in play! Analysts reshuffled the deck - who's your pick going into Friday? stocksrunner.com/news/2025-05-22-thursday-analyst-upgrades-and-downgrades

0 · Reply

Thestocktraderhubzee May. 22 at 4:02 PM

$INGN Inogen shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a $12 price target.

1 · Reply

erevnon May. 22 at 11:22 AM

Needham upgrades Inogen $INGN from Hold to Buy and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JarvisFlow May. 22 at 10:30 AM

Needham updates rating for Inogen ( $INGN ) to Buy, target set at 12.

0 · Reply

Estimize May. 14 at 8:03 PM

Wall St is expecting -0.23 EPS for $INGN Q2 [Reporting 08/12 AMC] http://www.estimize.com/intro/ingn?chart=historical&metric_name=eps&utm_c

0 · Reply

zecca1889 May. 8 at 2:33 PM

$INGN what happened if the accounts are fine?

0 · Reply

JarvisFlow Apr. 9 at 1:00 PM

Needham has adjusted their stance on Inogen ( $INGN ), setting the rating to Hold.

0 · Reply

Estimize Apr. 3 at 11:03 AM

Wall St is expecting -0.25 EPS for $INGN Q1 [Reporting 05/01 AMC] http://www.estimize.com/intro/ingn?chart=historical&metric_name=eps&utm_c

0 · Reply

Fugazi_ Mar. 31 at 7:43 PM

$INGN bought calls, somethings cookings

0 · Reply

zecca1889 Mar. 12 at 2:37 PM

$INGN https://www.zacks.com/stock/news/2428271/heres-why-you-should-retain-inogen-stock-in-your-portfolio-now?cid=CS-MKTWTCH-HL-analyst_blog|rank_focused-2428271&mod=mw_quote_news

0 · Reply

swingingtech Mar. 11 at 2:11 PM

$INGN $CAH $RMD $AVAH https://wallstreetwaves.com/top-reasons-to-keep-inogen-stock-in-your-investment-portfolio-today/

0 · Reply

redrussian Mar. 5 at 12:34 PM

$INGN 8.30 pre market

0 · Reply

Market Cap	166.97M
Revenue (ttm)	335.71M
Net Income (ttm)	-35.89M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-10.69%
Debt to Equity Ratio	0.00

Volume	223,900
Avg Vol	204,814
Day's Range	N/A - N/A
Shares Out	26.89M
Stochastic %K	20%
Beta	1.72
Analysts	Sell
Price Target	$11.67